GlassScriptPhysician profile
Vanessa D Dimas
NPI 1750572939
$7,303.65
in general payments reported to CMS, 2019-2025
18 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $733 · 2020: $89.64 · 2021: $135 · 2022: $1,974 · 2023: $459 · 2024: $3,320 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,969 · Food and Beverage: $1,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,969.02 |
| Food and Beverage | $1,403.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $3,710.13 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Musculoskeletal Transplant Foundation INC. | $2,313.29 | 2019-2024 | |
| Avita Medical Americas, LLC | $242.10 | 2019-2025 | Cohealyx, Permeaderm, Recell |
| Kls-Martin L.P. | $217.92 | 2025 | |
| Galderma Laboratories, L.P. | $149.21 | 2023-2025 | |
| Abbott Laboratories | $111.11 | 2022 | |
| Polarityte, INC. | $107.24 | 2019 | |
| Stryker Corporation | $89.64 | 2020 | |
| Tela Bio, INC. | $59.14 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $57.02 | 2022-2023 | Harmony |
| Kci USA, INC. | $52.43 | 2021-2022 | |
| Osteomed LLC | $36.83 | 2019 | |
| Sanara Medtech INC. | $31.35 | 2021 | |
| Medline Industries LP | $30.25 | 2024 | |
| Allergan, INC. | $28.59 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $26.19 | 2019 | |
| Acera Surgical, INC. | $23.18 | 2019 | |
| Hartmann USA, INC. | $18.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Dimas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.